Neurophysiology of Drug addiction Flashcards
Describe the core system in producing pleasure
VTA releases dopamine at nucleus Accumbens (Nac)
The VTA receives excitatory input from what 3 areas? what does each area release?
- Prefrontal cortex: EAA
- Lateral Hypothalamus: orexin
- Laterodorsal Tegmental N.: Acetylcholine
The VTA provides a domaminergic input to the Nac via what?
median forebrain bundle
Describe what the Nucleus Accumbens is of the striatum?
- third nucleus
- often referred to as the ventral striatum
In addition to dopaminergic VTA input, the Nac also receive excitatory inputs from where? what do they use?
- Prefrontal cortex
- Amygdala
- Hippocampus
all use EAA
The output from Nac is to where? uses what?
Prefrontal cortex
-uses GABA
The Nac also sends a GABA-ergic input BACK to where? what is the co transmitter released here also
- VTA
- Dynorphin
The opioid inputs to the VTA do what?
The inhibit a subset of GABA-ergic interneurons. This increases the release of dopamine in the Nac
What are the dopamine receptors in the Nac
- D1: activate direct
- D3: inhibit indirect (these predominate)
- the dopamine inhibits the Nac so it releases less GABA in prefrontal cortex leading to pleasure
what are the inputs that activate the VTA leading to the pleasure pathway
- Prefrontal cortex, laterodorsal tegmental nucleus: EAA
- Lateral Hypothalamic Nucleus: orexin
What activates the Nac and prevents pleasure
- Prefontal cortex, amygdala, hippocampus
- release EAA
what is the word used to describe the nature of opioid inputs that reinforces the occurrence of certain behaviors important for our survival
- Diffuse
- also activates locus ceruleus, Periquaductal Grey
what kind of feedback system is the pleasure/reward system
positive
Cannabis and Opiates activate G protein coupled receptors. Describe this further
- Opiates: agonist at opioid receptors, Gi
- Cannabis: CB-1 receptor, leads to dopamine release
What drugs alter ion channels
- Nicotine: agonist at nicotinic cholinergic receptors, influx of Na
- Ethanol/PCP: antagonist at NMDA receptors (weak)